Also, adoptive transfer of monocytes carrying CAMPs encapsulating IL‐4 and dexamethasone enabled persistent conversion of their phenotypes to anti‐inflammatory type, which allowed for modulation of both the brain and systemic immune responses and treatment of multiple sclerosis.48 Here, IL4 is linked to multiple sclerosis.